Time filter

Source Type

Nazarpak M.H.,Amirkabir University of Technology | Nazarpak M.H.,University of Tehran | Pourasgari F.,University of Tehran | Pourasgari F.,Stem Cells Technology Research Center | Sarbolouki M.,University of Tehran
Asian Biomedicine

Background: Scaffolds for bone tissue engineering must meet functional requirements, porosity, biocompatibility, and biodegradability. Different polymeric scaffolds have been designed to satisfy these properties. Composite materials could improve mechanical properties compared with polymers, and structural integrity and flexibility compared with brittle ceramics. Objective: Fabricate poly (lactic-co-glycolic acid) (PLGA) /hydroxyapatite (HA) porous scaffolds by freeze-extraction method, and evaluate the possibility for optimizing their biocompatibility by changing their HA content. Methods: Porous PLGA/HA composites structure were prepared by freezing a polymer solution, and then the solvent was extracted by a non-solvent and subsequently air-dried. The scaffolds were coated with triblock copolymer and sterilized by ultraviolet light. Human mesenchymal stem cells were cultured on the prepared scaffolds and were studied after three days by 4, 6-diamidino-2-phenylindole (DAPI) fluorescence microscopy. Results: Microstructural studies with SEM showed the formation of about 50 micrometer size porous structure and interconnected porosity so that cells were adhered well into the structure of the coated samples. DAPI fluorescence microscopy showed more cell adhesion to the coated scaffolds and cell diffusion into the pores are visible. Direct assay of cell proliferation performed with MTT test showed cell growing on the scaffold similar to or more than on control samples. Conclusion: The triblock-coated PLGA/HA porous scaffolds may provide cell adhesion and proliferation, demonstrating their potential application in bone engineering. Source

Eslami-Arshaghi T.,Stem Cells Technology Research Center | Salehi M.,Shahid Beheshti University of Medical Sciences | Soleimani M.,Tarbiat Modares University | Gholipourmalekabadi M.,Shahid Beheshti University of Medical Sciences | And 4 more authors.

Stem cells therapy is considered as an efficient strategy for the treatment of some diseases. Nevertheless, some obstacles such as probability of rejection by the immune system limit applications of this strategy. Therefore, several efforts have been made to overcome this among which using the induced pluripotent stem cells (iPSCs) and nuclear transfer embryonic stem cell (nt-ESCs) are the most efficient strategies. The objective of this study was to evaluate the differentiation potential of the nt-ESCs to lymphoid lineage in the presence of IL-7, IL-3, FLT3-ligand and TPO growth factors in vitro. To this end, the nt-ESCs cells were prepared and treated with aforementioned growth factors for 7 and 14 days. Then, the cells were examined for expression of lymphoid markers (CD3, CD25, CD127 and CD19) by quantitative PCR (q-PCR) and flow cytometry. An increased expression of CD19 and CD25 markers was observed in the treated cells compared with the negative control samples by day 7. After 14 days, the expression level of all the tested CD markers significantly increased in the treated groups in comparison with the control. The current study reveals the potential of the nt-ESCs in differentiation to lymphoid lineage in the presence of defined growth factors. © 2015 The International Alliance for Biological Standardization. Source

Khademi F.,Tehran University of Medical Sciences | Khademi F.,Stem Cells Technology Research Center | Soleimani M.,Stem Cells Technology Research Center | Soleimani M.,Tarbiat Modares University | And 6 more authors.
Cell Biology International

In spite of certain clinical limitations, such as teratoma formation, the use of stem cells is considered as an appropriate source in cell therapy and tissue engineering. This study shows human endometrial stem cells (hEnSCs) has exceptional differentiation ability in hepatocyte formation. hEnSCs have high purification rate and immune-tolerance, and can be used as an appropriate substitute for hepatocytes in liver disorders. Differentiation required hepatogenic medium. Quantitative reverse transcription-polymerase chain reaction and immunofluorescent staining of hepatic genes and proteins including cytokeratin 18 (ck18), alpha-fetoprotein (afp), and albumin (alb) were used to assess differentiation. Cells differentiated with a hepatocyte-like morphology and expressed hepatic markers on 30 days of differentiation. The Periodic Acid-Schiff (PAS) reaction showed storage of glycogen, and albumin and afp secretions were also detected. In vitro hEnSCs behave like hepatocyte after differentiation and may be a suitable source of cells in liver regeneration. © 2014 International Federation for Cell Biology. Source

Discover hidden collaborations